fashion -WSS

fashion

author：hotspot 2025-10-01 00:48:46 - browse：7

Medicare generally pays far more for CAR-T drugs that are administered in outpatient departments than it does for inpatient care. Adobe

WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. But that could soon change: if drug companies succeed in making the cancer treatments safer, hospitals could provide them more often in outpatient departments, where payment is higher.

CAR-T uses the body’s own immune system to kill cancerous cells. The procedure, regulated as a drug, involves taking T cells from a patient’s blood, adding chimeric antigen receptors (CAR) to the T cells that kill cancer, and injecting the CAR-T treatment back into the patient.

It’s worked wonders in many cancer patients who have run out of options. But right now it’s almost exclusively administered in hospitals, because the side effects can require aggressive treatments. In many cases, the CAR-T cells trigger immune reactions that can be life-threatening.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： 5 dead in mass shooting on Caribbean island of St. Vincent: Police

WSS

Delta passengers in Vegas fall sick while waiting on flight in triple

Extensive review finds private equity owners jack up cost of care

Patients, doctors press FTC to beef up hospital merger scrutiny

White House Covid adviser calls on docs to combat misinformation

In rare move, senator releases unverified FBI source report alleging Biden bribe

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

hotspot

fashion

focus

In Memoriam: Notable people who died in 2023

Judge denies Trump's request for new trial in E. Jean Carroll case

United colonoscopy coverage change 'may cost lives,' doctors say

Hormonal contraceptives don’t actually treat endometriosis

BioMarin wins approval for gene therapy to treat hemophilia A

The unintended consequences of overturning Roe v. Wade

State Dept. review finds Biden bears some blame for Afghanistan failures

5 dead in mass shooting on Caribbean island of St. Vincent: Police

Tori Bowie and the unacceptable rates of Black maternal death

Judge denies Trump's request for new trial in E. Jean Carroll case

hotspot

After a decade, new Gardasil ad campaign gets it (mostly) right

Transgender sports debate: Physicians say bans are health issue

Midwives could help bridge maternal health disparities in the U.S.

Extensive review finds private equity owners jack up cost of care

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Why the quest to eradicate polio has stumbled

hotspot

entertainment

hotspot

explore